Bookbuilding IPO | ā¹1,551 Cr | Listed at BSE, NSE | Fri, Aug 4, 2023 - Tue, Aug 8, 2023
Concord Biotech IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | QIB | NII | Retail | Employees | Total | ||||
|---|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | Above ā¹10L | Below ā¹10L | Total NII | ||||
| Allocation (No. of shares) | 2,09,25,652 | ||||||||
| Allotment price (ā¹) | 741 | ||||||||
| No. of applications | 11,44,890 | ||||||||
| No. of shares applied | 36,91,24,080 | ||||||||
|
š Preview Limited Full data is available exclusively on IPOMatrix.com ā your premium IPO research platform. šļø Login to View All Records → |
|||||||||
| Amount collected (ā¹ Cr.) | 27,350.86 Cr | ||||||||
| No. of times subscribed | 17.64 | ||||||||
| No. of shares allotted | 2,09,25,652 | ||||||||
| Amount allotted (ā¹ Cr.) | 1,550.52 Cr | ||||||||
| No. of allottees | 3,77,602 | ||||||||
Concord Biotech IPO is a public issue of 2.09 Cr equity shares. The issue offers 0.73 Cr shares to retail investors, 1.05 Cr shares to qualified institutional buyers, and 0.31 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| QIB | 1,04,57,825 | 774.92 | 49.98% |
| Anchor | 62,74,695 | 464.95 | 29.99% |
| QIB (Ex Anchor) | 41,83,130 | 309.97 | 19.99% |
| NII | 31,37,348 | 232.48 | 14.99% |
| bNII (> ₹10L) | 20,91,565 | 154.98 | 10.00% |
| sNII (< ₹10L) | 10,45,783 | 77.49 | 5.00% |
| Retail | 73,20,479 | 542.45 | 34.98% |
| Employee | 10,000 | 0.74 | 0.05% |
| Total | 2,09,25,652 | 1,550.59 | 100% |
A total of 62,74,695 shares at a price of Rs 741 per share will be allotted to the anchor investors.
| Bid Date | Aug 03, 2023 |
| Price | ā¹741.00 |
| % of QIBs | 60.00% |
| Shares Locked (30 Days) | 31,37,348 |
| Shares Locked (90 Days) | 31,37,348 |
| # | Anchor | Group Entity | Shares Allotted | Amt (₹ cr.) | % Allocated | % Allotment of Issue |
|---|---|---|---|---|---|---|
| 1 | GOVERNMENT OF SINGAPORE | GOVERNMENT OF SINGAPORE | 3,37,220 | 24.99 | 5.37 | 1.61 |
| 2 | ABU DHABI INVESTMENT AUTHORITY-STABLE | ABU DHABI INVESTMENT | 3,03,480 | 22.49 | 4.84 | 1.45 |
š Historic report - IPOs Anchor Investors Investment & Performance
The Concord Biotech IPO is subscribed 17.64x.
Category-wise data available on IPOMatrix.com
Login to view QIB, NII, Retail and all category details
| Category | Subscription (times) |
|---|---|
| Total | 17.64x |
Concord Biotech IPO total subscription is 17.64x.
Category-wise data available on IPOMatrix.com
Login to view QIB, NII, Retail and all category details
An investor can apply in Concord Biotech IPO online via bank (using ASBA) or the broker (using UPI). The Concord Biotech IPO shares are offered online only.
The Concord Biotech IPO is subscribed 17.64x times.
The Concord Biotech IPO allotment status is expected on or around Friday, August 11, 2023. Visit Concord Biotech IPO allotment status to check.
The Concord Biotech IPO listing date is August 18, 2023. The equity share of Concord Biotech IPO will list on BSE, NSE.
Visit Concord Biotech IPO subscription status page for real-time bidding information about Concord Biotech IPO.
| IPO opens On | Friday, August 4, 2023 |
| IPO Closes On | Tuesday, August 8, 2023 |
| Finalisation of Basis of Allotment | Friday, August 11, 2023 |
| Initiation of Refunds | Monday, August 14, 2023 |
| Credit of Shares to Demat Account | Thursday, August 17, 2023 |
| IPO Listing Date | Friday, August 18, 2023 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO FAQs |
